Navigation Links
Onyx Pharmaceuticals to Present at the Credit Suisse 18th Annual Healthcare Conference
Date:11/4/2009

EMERYVILLE, Calif., Nov. 4 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at the Credit Suisse 18th Annual Healthcare Conference on Wednesday, November 11, at 9:30 a.m. Mountain Time (8:30 a.m. Pacific Time). Interested parties may access a live webcast of the presentation on our website at: http://www.onyx-pharm.com/view.cfm/32/Event-Calendar

It is recommended that listeners log on 15 minutes early in order to register and download any necessary software. For those unable to participate during the live webcast, a recorded replay of the presentation will be available one hour following the conclusion of the presentation through December 11, 2009.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar®, a small molecule drug. Nexavar is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in a variety of tumor types. For more information about Onyx, visit the company's website at www.onyx-pharm.com.

Nexavar® (sorafenib) tablets is a registered trademark of Bayer HealthCare Pharmaceuticals.

SOURCE Onyx Pharmaceuticals, Inc.


'/>"/>
SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Optimer Pharmaceuticals Reports Third Quarter 2009 Financial Results
2. ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results
3. Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update
4. OncoGenex Pharmaceuticals to Release Third Quarter 2009 Financial Results
5. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2009 Financial Results on November 5, 2009
6. Transdel Pharmaceuticals to Present at Two Investor Conferences
7. Lotus Pharmaceuticals, Inc. Announces 2010 Growth Strategy
8. Amylin Pharmaceuticals to Webcast Third Quarter Results
9. Angiotech Pharmaceuticals, Inc. Announces Conference Call and Webcast
10. OncoGenex Pharmaceuticals CEO Named Canadas Pacific Ernst & Youngs Entrepreneur Of The Year(R) in the Health Sciences Category
11. United States Securities and Exchange Commission Declares Effective Registration Statement for NeoStems Acquisition of China Biopharmaceuticals Holdings, Inc. and a Controlling Interest in Leading Chinese Pharmaceutical Company; Meeting of Each Com

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...SANDIEGO,Nov.25/PRNewswire-FirstCall/--ArdeaBiosci...Quart,Pharm.D.,presidentandchiefexecutiveofficer,w...ference. , ,Presentationdetailsareasfollows:,Pip...ay,December1,2009,Time:2:00p.m.EasternTime,Locatio...,http://www.corporate-ir.net/ireye/,target=,_blan...
(Date:11/24/2009)... The New York investment bank KTA...NEU) has agreed an AU$6.7 mil convertible note pri... The private placement was arranged by KTA Capital.... , New York (PRWEB) Nove...nt bank KTA Capital, LLC ("KTA Capital")...
(Date:11/24/2009)...ST.LOUIS,Nov.24/PRNewswire-FirstCall/--Sigma-Aldri...ASDAQOMXconferenceonTuesday,December1stat1:45PMGMT...aliveaudiobroadcastovertheInternetavailableat htt...canclickthe"Webcast"icontoaccessthisfile. ,, ...ienceandHighTechnologycompany.Itschemicalandbioche...
(Date:11/24/2009)...SANMATEO,Calif.,Nov.24/PRNewswire-FirstCall/--Neur...yfocusedondevelopingandcommercializingnovelpainman...PresidentandChiefExecutiveOfficer,isscheduledtopre...e,tobeheldDecember1-2,2009atTheNewYorkPalaceHoteli...eri,ChiefFinancialOfficer,willbeavailabletorespond...
Breaking Biology Technology:Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3
...rd Blood America, Inc.,(OTC Bulletin Board: CBAI),...ompany ( http://www.cordblood-america.com ) focus...ells to families nationwide and internationally,to...phia, Pa., which it,acquired in October 2006, had ...r the three months ending March 31, 2008., CorCel...
... Inverness Medical,Innovations, Inc. (Amex: IMA )...gnostic products for the consumer and professional...upcoming FBR Capital Markets 12th Annual,Spring In...rand Hyatt in,New York. Ron Geraty, President, Hea...inance, will attend. Their presentation is schedul...
...Dialysis Patients with Compatible Treatment Option...ding,provider of kidney care services for those di...KD), recently introduced "Treatment Evaluator", an...tion about the different,dialysis modalities DaVit...onversation with their nephrologist to determine w...
Other Biology Technology:Cord Blood America Reports CorCell, Its Major Acquisition in 2006, Turns Profitable 2Inverness Medical Innovations to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 28, 2008 2DaVita Introduces 'Treatment Evaluator' 2
(Date:11/23/2009)... of the highest resolution images of peptides atta...r understanding how biomolecules manipulate the gr...atment for kidney stones using biomolecules. , T...dition of the journal Proceedings of the National...act with mineral surfaces by accelerating, switchi...
(Date:11/23/2009)...pshire microbiologist Louis Tisa has received two ...of the actinorhizal plants, widespread woody plant...minated soils. , The United States Department o...molecular, cellular and biomedical sciences, $399,...the bacteria Frankia and Casuarina, an actinorhiza...
(Date:11/23/2009)...iscoveries about the multiple health benefits of v...e nutrient, increased awareness of the huge number...rch and even led to an appreciation of it as "natu...ealth of your immune system to prevention of heart...min D is now seen as one of the most critical nutr...
Breaking Biology News(10 mins):Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3UNH prof. receives nearly $500,000 to research environmentally significant plants 2Multiple health concerns surface as winter, vitamin D deficiences arrive 2Multiple health concerns surface as winter, vitamin D deficiences arrive 3NJIT US Marine Corps Reserve Association host counter terrorism symposium 10696 1For Older Walkers Faster Is Better 61159 1Uninsured Issue Takes Center Stage This Weekend in New Orleans 61155 1
...ve discovered that a frog that lives near noisy sp...ent sound frequencies, much like the tuner on a ra... the only known example of an animal that can acti...hers say. , The findings, from a collaborative ef...versity of California at Los Angeles, appear this ...
...reserves where fishing is banned can have benefits...specifically designed to protect, according to new...rted in the July 22nd issue of Current Biology , ...hat outbreaks of large, predatory crown-of-thorns ...te coral reefs, occur less often in protected zone...
...n a quiet stroll in the park can dramatically chan... conservation biologists from the University of Ca...rtant implications for land management policies. ,...y Area that allow only quiet recreation such as hi...at allow no public access. Evidence of some native...
Other Biology News:Ultrasonic frogs can tune their ears to different frequencies 2Ultrasonic frogs can tune their ears to different frequencies 3Fishing ban guards coral reefs against predatory starfish outbreaks 2Outdoor enthusiasts scaring off native carnivores in parks 2Outdoor enthusiasts scaring off native carnivores in parks 3Outdoor enthusiasts scaring off native carnivores in parks 4
...king pen has been designed to provide a thin film-...cimen on a slide. This barrier creates the proper...in the target area on the slide. PAP Pen contains...ol and acetone. It can be removed, if desired, by...
Mouse Anti-Human QDPR Monoclonal Antibody, Unconjugated, Clone 2D4-1D3 from Novus Biologicals
Agilent 1200 Series HPLC-Chip/MS System from Agilent Technologies
Rabbit Anti-Conjugated Quinaldic Acid Polyclonal Antibody, Unconjugated from Advanced Targeting Systems
Biology Products: